若不治疗耐多药结核病的危险。
The risk of leaving multidrug-resistant tuberculosis untreated.
他们要知道，治疗耐多药结核病费用极其昂贵，因此，他们要从绿灯委员会那里寻求援助，确保二线药物供应。
They have to know that treating MDR-TB can be very, very expensive – so they have to look for help from the Green Light Committee in securing the second-line drugs.
到2005年，绿灯委员会行动已积累了足够的证据，为制定在贫困环境中治疗耐多药结核病的新世卫组织政策铺平了道路。
By 2005, the Green Light Committee Initiative had accumulated enough evidence to pave the way for a new WHO policy on treating MDR-TB in poor Settings.
应用推荐